FDA Inspection 1152983 — TacPro LLC DBA Creganna Medical
The FDA completed an inspection of TacPro LLC DBA Creganna Medical on September 3, 2021 in Campbell, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 3, 2021
- Fiscal Year
- 2021
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Campbell, CA (United States)
Additional Details
Postmarket Audit Inspections